Wart Corn Remover

Description

The product is a topical solution formulated with salicylic acid as the active ingredient, which serves as a keratolytic agent to facilitate the shedding of the outer layer of skin. This solution is characterized by its clear and colorless appearance. In addition to salicylic acid, the formulation includes inactive ingredients such as alcohol, water, propylene glycol, and other unspecified excipients. The SPL Code for this product is 34089-3.

Uses and Indications

This drug is indicated for the topical treatment of warts and calluses. Prior to application, the affected area should be cleaned and dried thoroughly. The product is to be applied directly to the wart or callus by opening the bottle cap and dispensing the solution onto the affected area. It is essential to allow the solution to fully absorb and dry completely. In cases where the wart or callus is particularly large, an extended application time may be utilized to enhance effectiveness.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage for the removal of warts, including plantar warts, fat warts, common warts, corns, and calluses, is to apply the treatment three times a day. This regimen should be followed for a duration of 7 to 14 days, depending on the specific condition and response to treatment.

Healthcare professionals should ensure that the application is performed consistently at the prescribed intervals to maximize efficacy. It is important to monitor the treatment area for any signs of irritation or adverse reactions during the course of therapy.

Contraindications

Use of this product is contraindicated in the following situations:

Application on damaged skin is prohibited, including areas affected by cuts, abrasions, eczema, or sunburn, due to the potential for irritation and adverse reactions.

Patients with known allergies to any of the product's ingredients should not use this product, as this may lead to severe allergic reactions.

The use of this product is also contraindicated in pregnant or breastfeeding individuals unless specifically directed by a healthcare professional, to avoid potential risks to the mother or child.

Warnings and Precautions

For external use only. This product is contraindicated for application on damaged skin, including areas affected by cuts, abrasions, eczema, or sunburn. Caution is advised for individuals with known allergies to any of the ingredients contained in this formulation.

Healthcare professionals should advise patients who are pregnant or breastfeeding to consult a physician before using this product, as its safety in these populations has not been established without medical guidance.

Patients should be instructed to discontinue use and seek medical advice if they become pregnant or are planning to become pregnant while using this product. Additionally, if irritation or redness occurs, or if the condition worsens or fails to improve after regular use, patients should promptly contact their healthcare provider.

In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Side Effects

Patients using this product should be aware that it is intended for external use only. In the event of pregnancy or if planning to become pregnant while using this product, it is advised to discontinue use immediately.

Common adverse reactions may include irritation or redness at the application site. If these symptoms occur, patients should stop using the product. Additionally, if the condition being treated worsens or does not improve after regular use, it is recommended to cease application and consult a healthcare professional.

It is crucial to keep this product out of reach of children. In the case of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center without delay.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Wart Corn Remover (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should use this product only under adult supervision. It is essential for caregivers to monitor the use of this product to ensure safety and efficacy in children.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients or those planning to become pregnant while using this product should be aware of the potential risks associated with its use. There is limited data regarding the safety of this product during pregnancy, and it is recommended that pregnant patients consult their healthcare provider before continuing use. Additionally, breastfeeding is not advised unless directed by a healthcare professional, as the effects on nursing infants are not well established. Healthcare providers should weigh the potential benefits against the risks when considering the use of this product in pregnant or breastfeeding patients.

Lactation

Lactating mothers should use this medication only if directed by a healthcare professional. There is no available data on the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is advised when administering this medication to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data regarding its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

The use of this product during pregnancy or while planning to become pregnant may pose teratogenic risks. It is advised that individuals who are pregnant or breastfeeding should only use this product under the guidance of a healthcare professional, as non-teratogenic effects may still be a concern in these populations.

No specific data regarding carcinogenicity, mutagenicity, or detailed animal pharmacology and toxicology studies were provided.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion or misuse. Patients should be informed that the product should not be applied to damaged skin, including areas with cuts, abrasions, eczema, or sunburn, as this may exacerbate irritation.

It is essential to discuss the importance of checking for allergies to any of the ingredients in the product prior to use. Patients who are pregnant, breastfeeding, or planning to become pregnant should only use this product if directed by a healthcare professional. They should be instructed to report any irritation or redness that occurs during use, as well as any worsening of their condition or lack of improvement after regular use.

In the event of accidental ingestion, patients should seek medical help or contact a Poison Control Center immediately. Providers should emphasize the need to avoid contact with the eyes; if contact occurs, patients should flush their eyes thoroughly with water.

Patients should be cautioned against swallowing the product and reminded that children should use it only under adult supervision. Additionally, it is important to advise patients to avoid prolonged exposure to air while using the product, as the liquid can easily volatilize and crystallize. They should also be instructed to tighten the cap after each use and to be aware of the integrity of the seal, ensuring it is not broken or missing.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity and effectiveness.

To ensure optimal preservation, users must avoid prolonged exposure to air during usage, as this can lead to volatilization and crystallization of the liquid. After each use, it is crucial to securely tighten the cap to prevent any air exposure. If the seal is found to be broken or missing, the product should not be used to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with a recommended application frequency of three times a day for a duration of 7 to 14 days. Clinicians should counsel patients on several important considerations. Patients should inform their healthcare provider if they become pregnant or are planning to become pregnant while using the product. They should also report any irritation or redness, or if their condition worsens or does not improve after regular use.

It is crucial to keep the product out of reach of children, and in the event of ingestion, medical assistance or contact with a Poison Control Center should be sought immediately. The product should not be applied to damaged skin, including cuts, abrasions, eczema, or sunburn, and individuals with known allergies to any ingredients should avoid use. Pregnant or breastfeeding patients should only use the product if directed by a healthcare professional. Additionally, patients should avoid contact with eyes and ensure that the product is tightly capped after each use to prevent volatilization and crystallization. Children should use the product only under adult supervision.

Drug Information (PDF)

This file contains official product information for Wart Corn Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)